Sentences with phrase «funds at large discounts»

The author starts by giving a preview of where he will end — with Carl Icahn when he was much younger, where he was buying closed - end funds at large discounts, and pressuring managers to liquidate the fund.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

By self - funding, Cavale could force INFLCR to build its own track record with its product, clients and revenues, and ultimately raise a seed round at what he believes to be a fair valuation as opposed to giving up a large piece of his new company at a discount, which is often an issue with raising money pre-revenue.

Funding its ballooning deficit, which can't be plugged with asset sales and debt issuance alone, and improving its economic situation are partly why Saudi Arabia, the largest producer in the OPEC oil cartel, disagreed to any cut in production at the December OPEC meeting, and more recently has been discounting the price of oil to its customers.

Carl Icahn got his start as a closed end fund arbitrageur, who would force the managements of the closed - ends funds that traded at large discounts to NAV, to buy - back their shares.

A2 plans to offer 40 million shares at NZ50 cents a share, a discount to the market price of NZ68 cents, while its three largest shareholders — Freedom, Mountain Road Investments and EGI - Fund investors — have agreed to sell up to 140 million shares, increasing liquidity in the company.

Less trading volume results in larger bid / ask spreads, and thus bond funds trade at premiums and discounts to the actual value of the bonds backing up the fund.

But we have 20 % of the Value Fund invested in US commercial property trading at a large discount to asset value (via ASX listed trusts), are giving serious consideration to QBE Insurance and News Corporation and searching for others that are not correlated with resource prices or the domestic economy.

The problem is that robos tend to include more «esoteric» funds, ones that not only trade with a larger spread between bid and ask prices (translation: higher cost to you), but also trade at a discount or premium to the underlying assets in the ETF (translation: higher costs to you if the manager buys at a premium or sells at a discount to asset value).

Eyquem Fund LP systematically targets stocks at the largest discount from their full change ‐ of ‐ control value with the highest probability of undergoing a near ‐ term catalytic change ‐ of ‐ control event.

Finally, closed - end mutual funds that trade at large discounts to their net asset values are also considered good investments.